Shopping Cart 0
Cart Subtotal
USD 0

BioMmune Technologies Inc (IMU)-Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 300

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 600

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 900
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

BioMmune Technologies Inc (BioMmune Technologies) is a biopharmaceutical company that specializes in the discovery and development of new drugs in the field of immunotherapy. The company advances technologies developed at The University of British Columbia, which can control the immune activity and improve their ability to attack cancers, infections and autoimmune diseases. Its research programs include Major Histocompatibility Complex I (MHC I), that restores the immune system's ability to recognize and destroy cancer cells; calcium channel blockers, that modulates voltage-gated calcium channels for the signalling of immune system response and prevents transplant rejection; and CD74, a chaperone protein that aids the immune system to combat infections and cancers. BioMmune Technologies is headquartered in Vancouver, British Columbia, Canada.

BioMmune Technologies Inc Key Recent Developments

Sep 20, 2016: BioMmune Appoints Thomas Gadek, PhD, to Board of Directors

Jun 29, 2016: BioMmune, A 2016 TSX Venture Top 50 Company, Awarded Patent for Calcium Channel Monoclonal Antibodies

Apr 22, 2016: BioMmune Appoints Dr. Patrick Gray as New Chief Executive Officer and President

This comprehensive SWOT profile of BioMmune Technologies Inc provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData's 'Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of BioMmune Technologies Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

READ MORE

Table Of Content

Scope

Table of Contents

Section 1-About the Company

BioMmune Technologies Inc-Key Information

BioMmune Technologies Inc-Overview

BioMmune Technologies Inc-Key Employees

BioMmune Technologies Inc-Key Employee Biographies

BioMmune Technologies Inc-Key Operational Heads

BioMmune Technologies Inc-Major Products and Services

BioMmune Technologies Inc-History

BioMmune Technologies Inc-Company Statement

BioMmune Technologies Inc-Locations And Subsidiaries

BioMmune Technologies Inc-Key Manufacturing facilities

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

BioMmune Technologies Inc-Business Description

BioMmune Technologies Inc-Corporate Strategy

BioMmune Technologies Inc-SWOT Analysis

SWOT Analysis-Overview

BioMmune Technologies Inc-Strengths

BioMmune Technologies Inc-Weaknesses

BioMmune Technologies Inc-Opportunities

BioMmune Technologies Inc-Threats

BioMmune Technologies Inc-Key Competitors

Section 3-Company Financial Performance Charts

BioMmune Technologies Inc-Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Appendix

Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

Note*: Some sections may be missing if data is unavailable for the company


List Of Figure

List of Figures

BioMmune Technologies Inc, Performance Chart

BioMmune Technologies Inc, Ratio Charts


List Of Table

List of Tables

BioMmune Technologies Inc, Key Information

BioMmune Technologies Inc, Key Ratios

BioMmune Technologies Inc, Share Data

BioMmune Technologies Inc, Major Products and Services

BioMmune Technologies Inc, History

BioMmune Technologies Inc, Key Employees

BioMmune Technologies Inc, Key Employee Biographies

BioMmune Technologies Inc, Key Operational Heads

BioMmune Technologies Inc, Other Locations

BioMmune Technologies Inc, Subsidiaries

BioMmune Technologies Inc, Key Manufacturing facilities

BioMmune Technologies Inc, Key Competitors

BioMmune Technologies Inc, SWOT Analysis

BioMmune Technologies Inc, Ratios based on current share price

BioMmune Technologies Inc, Annual Ratios

BioMmune Technologies Inc, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com